ARTICLE | Company News
Ribi ImmunoChem Inc. other research news
September 25, 1995 7:00 AM UTC
The Hamilton, Mont., company's MPL lipid A adjuvant stimulated cellular immunity in animal tests.
An HIV vaccine using oligomeric gp160 HIV protein and MPL lipid A enhanced cellular proliferative responses against the antigen in mice and rabbits, as well as cytolytic T lymphocyte activity against a V3 peptide segment of HIV. ...